JPS51118777A - Preparation method of new pyrimidine derivatives - Google Patents

Preparation method of new pyrimidine derivatives

Info

Publication number
JPS51118777A
JPS51118777A JP50080752A JP8075275A JPS51118777A JP S51118777 A JPS51118777 A JP S51118777A JP 50080752 A JP50080752 A JP 50080752A JP 8075275 A JP8075275 A JP 8075275A JP S51118777 A JPS51118777 A JP S51118777A
Authority
JP
Japan
Prior art keywords
preparation
pyrimidine derivatives
new pyrimidine
new
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50080752A
Other languages
English (en)
Japanese (ja)
Inventor
Marii Kuraberii Jiyan
Matsuteioda Jiyorujiyu
Miyuishie Rune
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GEN RUSHIERUSHIYU E APPLIC SHI
JIENERARU DO RUSHIERUSHIYU E DAPURIKASHION SHIANTEIFUIKU SOJIERASU SOC
Original Assignee
GEN RUSHIERUSHIYU E APPLIC SHI
JIENERARU DO RUSHIERUSHIYU E DAPURIKASHION SHIANTEIFUIKU SOJIERASU SOC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by GEN RUSHIERUSHIYU E APPLIC SHI, JIENERARU DO RUSHIERUSHIYU E DAPURIKASHION SHIANTEIFUIKU SOJIERASU SOC filed Critical GEN RUSHIERUSHIYU E APPLIC SHI
Publication of JPS51118777A publication Critical patent/JPS51118777A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47—One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32—One oxygen, sulfur or nitrogen atom
    • C07D239/34—One oxygen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
JP50080752A 1975-04-10 1975-06-30 Preparation method of new pyrimidine derivatives Pending JPS51118777A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7511154A FR2306697A1 (fr) 1975-04-10 1975-04-10 Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants

Publications (1)

Publication Number Publication Date
JPS51118777A true JPS51118777A (en) 1976-10-18

Family

ID=9153719

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50080752A Pending JPS51118777A (en) 1975-04-10 1975-06-30 Preparation method of new pyrimidine derivatives

Country Status (12)

Country Link
US (1) US3984411A (OSRAM)
JP (1) JPS51118777A (OSRAM)
BE (1) BE829845A (OSRAM)
CA (1) CA1036597A (OSRAM)
CH (1) CH603626A5 (OSRAM)
DE (1) DE2528360A1 (OSRAM)
ES (1) ES439017A1 (OSRAM)
FR (1) FR2306697A1 (OSRAM)
GB (1) GB1502182A (OSRAM)
IT (1) IT1036400B (OSRAM)
LU (1) LU72743A1 (OSRAM)
NL (1) NL7507441A (OSRAM)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU176972B (hu) * 1977-06-13 1981-06-28 Gyogyszerkutato Intezet Sposob poluchenija novykh proizvodnykh piridazinil-gidrazona
US4648896A (en) * 1982-11-15 1987-03-10 Ciba-Geigy Corporation 2-aryl-4,6-dihalopyrimidines as antidote for protecting cultivated plants from phytotoxic damage caused by herbicides
FI895821A7 (fi) * 1988-12-07 1990-06-08 The Wellcome Foundation Ltd Farmaseuttisesti aktivisia CNS-yhdisteitä
EP1034174B1 (en) * 1997-11-05 2003-08-13 Neurosearch A/S Azaring-ether derivatives and their use as nicotinic ach receptor modulators
DE602004009295T2 (de) 2003-01-14 2008-07-03 Arena Pharmaceuticals, Inc., San Diego 1,2,3-trisubstituierte aryl- und heteroarylderivate als modulatoren des metabolismus zur vorbeugung und behandlung von metabolismus-bedingten krankheiten wie diabetes oder hyperglykämie
JP2006518763A (ja) * 2003-02-24 2006-08-17 アリーナ ファーマシューティカルズ， インコーポレイテッド グルコース代謝のモジュレーターとしてのフェニル−およびピリジルピペリジン誘導体
AR045047A1 (es) 2003-07-11 2005-10-12 Arena Pharm Inc Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos
CA2441775C (en) * 2003-09-23 2004-09-28 Westport Research Inc. Container for holding a cryogenic fluid
ATE415397T1 (de) * 2004-06-04 2008-12-15 Arena Pharm Inc Substituierte aryl- und heteroarylderivate als modulatoren des stoffwechsels und für die prophylaxe und behandlung von damit in zusammenhang stehenden erkrankungen
MY148521A (en) * 2005-01-10 2013-04-30 Arena Pharm Inc Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto
DOP2006000010A (es) 2005-01-10 2006-07-31 Arena Pharm Inc Procedimiento para preparar eteres aromáticos
DE602006006461D1 (de) * 2005-09-16 2009-06-04 Arena Pharm Inc Stoffwechselmodulatoren und behandlung damit verbundener erkrankungen
TW200811147A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
TW200811140A (en) * 2006-07-06 2008-03-01 Arena Pharm Inc Modulators of metabolism and the treatment of disorders related thereto
EP2181098B1 (en) 2007-08-30 2011-03-02 Dow AgroSciences LLC 2-(substituted phenyl)-6-amino-5-alkoxy, thioalkoxy and aminoalkyl-4-pyrimidinecarboxylates and their use as herbicides
SG10201500639TA (en) 2010-01-27 2015-03-30 Arena Pharm Inc Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof
PH12013500547A1 (en) 2010-09-22 2013-06-10 Arena Pharm Inc Modulators of the gpr119 receptor and the treatment of disorders related thereto
ES2995737T3 (en) 2015-01-06 2025-02-11 Arena Pharm Inc Compound for use in treating conditions related to the s1p1 receptor
CA2986611C (en) 2015-06-15 2023-10-03 Nmd Pharma Aps Compounds for use in treating neuromuscular disorders
MA42807A (fr) 2015-06-22 2018-07-25 Arena Pharm Inc Sel l-arginine cristallin d'acide (r)-2-(7-(4-cyclopentyl-3-(trifluorométhyl)benzyloxy)-1,2,3,4-tétrahydrocyclo-penta[b]indol-3-yl)acétique (composé 1) pour une utilisation dans des troubles associés au récepteur de s1p1
WO2018151873A1 (en) 2017-02-16 2018-08-23 Arena Pharmaceuticals, Inc. Compounds and methods for treatment of primary biliary cholangitis
US12440477B2 (en) 2017-12-14 2025-10-14 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US10385028B2 (en) 2017-12-14 2019-08-20 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11591284B2 (en) 2017-12-14 2023-02-28 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11147788B2 (en) 2017-12-14 2021-10-19 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
US11730714B2 (en) 2017-12-14 2023-08-22 Nmd Pharma A/S Compounds for the treatment of neuromuscular disorders
EP3801459B1 (en) 2018-06-06 2024-08-07 Arena Pharmaceuticals, Inc. Methods of treating conditions related to the s1p1 receptor

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3259623A (en) * 1963-06-14 1966-07-05 Olin Mathieson Process for preparing 2-(secondary amino)-halogenopyrimidines
US3261833A (en) * 1964-10-20 1966-07-19 Smith Kline French Lab 2,4-diamino-6-aminoalkoxy pyrimidines
GB1143167A (en) * 1967-01-25 1969-02-19 Ucb Sa Derivatives of pyrimidine

Also Published As

Publication number Publication date
DE2528360A1 (de) 1976-10-21
FR2306697A1 (fr) 1976-11-05
FR2306697B1 (OSRAM) 1979-08-10
CA1036597A (fr) 1978-08-15
LU72743A1 (OSRAM) 1975-10-08
ES439017A1 (es) 1977-06-16
GB1502182A (en) 1978-02-22
BE829845A (fr) 1975-12-04
US3984411A (en) 1976-10-05
CH603626A5 (OSRAM) 1978-08-31
NL7507441A (nl) 1976-10-12
IT1036400B (it) 1979-10-30

Similar Documents

Publication Publication Date Title
JPS51118777A (en) Preparation method of new pyrimidine derivatives
GR60854B (en) Preparation process of benzylidenic derivatives
GR62109B (en) Preparation process of quinazolone derivatives
GR59797B (en) Preparation process of thieno-pyridine derivatives
BG27554A3 (en) Method of obtaining of derivatives of 2- aroyl- 3- phenyl- bewzothiophenes
JPS51113878A (en) Preparation method of new indolylpiperidine
JPS51136672A (en) Preparation method of 33methylpyridine
GR62466B (en) Preparation process of new optionally racemic pyrimidine derivatives
PT66498A (en) Process for preparation of new n-phosphonomethylglicine derivatives
GR63193B (en) Preparation process of thioured derivatives
CS194236B2 (en) Method of preparing derivatives of 4-oxo-hexahydro-4h-pyrazino-isoquinoline
BG27555A3 (en) Method of obtaining of derivatives of aroyl- phenilnaphtalenes
JPS51115485A (en) Preparation method of quinoxalineedioxide derivatives
CS189020B2 (en) Method of producing new derivatives of triaminoandrostane
ZA767100B (en) Method of producing 5-fluorouracil derivatives
JPS52274A (en) New preparation method of tetrahydrooalphaapyron derivatives
GR58595B (en) Preparation method of thieno-pyridines derivatives
JPS51138685A (en) Preparation method of 22aminoo 33hydroxypyridin derivatives
GR59327B (en) Preparation process of alkaloid derivatives
GR60349B (en) Preparation process of hydrazinopyridazine derivatives
JPS51128973A (en) Preparation method of aminopyridine
JPS5259176A (en) Preparation method of 55 aminocarbonyll2*4*66trihydroxyy pyrimidine
JPS5210281A (en) Preparation method of 2*44diamino 55*3*4*55trimethoxybenzyl** pyrimidine
SG783G (en) Method of producing 5-fluorouracil derivatives
PT68268A (en) Preparation process of new pyrimidine derivatives